EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Update

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 39,841 shares, a decrease of 79.3% from the June 15th total of 192,041 shares. Based on an average daily trading volume, of 280,156 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s shares are short sold.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ESLOY shares. Zacks Research downgraded shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd. Deutsche Bank Aktiengesellschaft began coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They set a “hold” rating on the stock. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy”.

EssilorLuxottica Price Performance

OTCMKTS:ESLOY traded down $0.27 during trading hours on Friday, hitting $97.79. 61,664 shares of the company were exchanged, compared to its average volume of 111,231. EssilorLuxottica has a one year low of $91.57 and a one year high of $186.81. The company has a fifty day simple moving average of $100.52 and a 200 day simple moving average of $123.90. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.